It was great to join the Convenzis team again for the patient flow event. As always, the team were incredibly accommodating and happy to help. The quality of attendees is always of a high standard and relevant to the patient flow and to us also. We continue to have great discussions and footfall around our stand with no need to try and encourage people to come and see us. Really positive event for us and we look forward to working with Convenzis in the future.
Clinerion
Clinical trials are “the single best way to turn advances in science into patient benefits” (Professor Nick James, ICR London).(1) And whilst over 95% of oncology patients thought it was important to be offered the option of participating in a trial during treatment, only 37% were actually offered to participate.(1) Additionally, during the pandemic, patient access to commercial trial opportunities in the UK has dropped by 44%.(2) At Clinerion we are passionate about changing this statistic. We are using data to accelerate the development of medicines and enabling more research opportunities for our population. We support healthcare organisations across the world to utilise their electronic healthcare records (EHR) in real-time: to visualise patient cohorts, streamline and enhance patient identification and feasibilities for clinical trials. This all happens securely through our Patient Network Explorer platform which is easy to use and can link with any EHR system.
Oncology clinical trials in particular can be challenging to recruit to, often with granular inclusion criteria. Sites using Patient Network Explorer can help you to find more eligible patients quicker, compared to more traditional, manual methods of patient identification.
Inherently collaborative, flexible, and transparent in our operations, we are looking for innovative healthcare organisations who want to create a powerful partnership with us. We can support you to streamline your research operations and improve performance, plus being part of our global network can increase commercial trial and collaboration opportunities for your site and patients.
Are you a clinician who sees the value of data to improve patient care? Then we want to speak to you! We are using our federated machine learning technology to create analytical dashboards to visualise patient cohorts, predictive modelling, and therapeutic insights.
We are looking forward to meeting you at the NHS Oncology North Conference!
References:
1) https://www.icr.ac.uk/news-archive/cancer-trial-recruitment-drops-by-60-per-cent-during-pandemic
